A previously asym ptom atic 30 year old m an presented w ith rhabdom yolysis, muscle weakness, an d acute encephalo pathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. U rinary excretion o f carnitine and glycine esters an d biochem ical exam ination o f skeletal m uscle and fibroblasts led to the diagnosis o f m e d iu m chain acyl-CoA dehydrogenase (M C A D ) deficiency.
Rhabdomyolysis (acute muscle necrosis) can be due to various acquired or hereditary causes. 12 The hereditary causes include spe cific defects of metabolism-for example, enzyme defects in glycogen catabolism and glycolysis. ^ Of the disorders of muscle lipid metabolism, carnitine palmitoyltransferase deficiency is one of the most common meta bolic causes of rhabdomyolysis/1 Recurrent attacks of rhabdomyolysis have been found in three patients reported to have myopathic car nitine deficiency. [5] [6] [7] Recently a few other defects of fatty acid oxidation have been asso ciated with rhabdomyolysis.H " 10 Medium chain acyl-CoA dehydrogenase (MCAD) deficiency is thought to be the most common disorder of fatty acid oxidation.1 1 1 1 As an inborn error of metabolism it has been recognised with increasing frequency in chil dren with a Reye-like syndrome. As a conse quence of the disturbance in fatty acid oxidation, M CAD deficiency is associated with acute attacks of hypoketotic hypoglycaemia and Cfi-Ci<} dicarboxylic aciduria. The attacks are provoked by stress, fever, viral illness, and fasting. Some patients, earlier classified as having carnitine deficiency, later seemed to have MCAD deficiency. 13 In urine a characteristic profile of C 6-Ci(> acylcarnitines can usually be shown, as well as acylglycines (for example, suberylglycine). The presence of octanoylcarnitine in plasma may be a specific indication for M CAD deficiency. 1 5 The age of initial presentation of M CAD deficiency varies widely. Most patients pre sent acutely, usually between infancy and the second year of life. Duran et al described an asymptomatic adult man, 1 6 Recent D N A studies have shown a high prevalence of a point mutation at nucleotide position 985 of the coding region of the M C A D gene in patients deficient in M C A D . 1 7 Here we describe the first patient with an initial clinical presentation of rhabdomyolysis and acute encephalopathy in adult life, who was later proved to have M CAD deficiency, established both at the enzyme and D N A level. A 30 year old man developed progressive muscle weakness in his arms and legs after a day of strenuous exercise in the cold without taking any food. He complained of headache and nausea, began vomiting, and produced dark brown coloured urine. At the end of the day he became lethargic, irritable, and agi tated. He was admitted with lowered con sciousness. He had had another episode of vomiting, headache, and motor restlessness one year before. This occurred during a long motorbike trip during which he did not eat. It was said that he sometimes had an acetone like breath, especially when he had not eaten. The family history was non-contributory.
Case history
On admission the patient was delirious. Blood pressure, pulse rate, and temperature were normal. Due to generalised muscle weakness, he was unable to stand upright. Muscle stretch reflexes were normal and sym metric. His liver was not enlarged. There was no focal neurological deficit. On admission creatine kinase activity in serum was 4000 IU/1 (normal range 15-91 IU/1) and myoglo bin was 134 /¿g/1 (normal < 85 f.igi\). The cal cium concentration of 2-20 mmol/1 was low normal (normal range 2*20~2'60). Phosphate concentrations were increased to 1*70 mmol/1 (normal range 0*76-1'24). Blood glucose was normal. Activity of transaminases in serum was raised, whereas y-glutamyltransferase activity was normal. Potassium concentration was increased to 5-8 mmol/1 (normal range 3*3-4-4 mmol/1). The patient had a low uri nary output for two days (500 ml per 24 hours). A transient increase of plasma urea to 26 mmol/1 (normal range 3' 1-7 *5 mmol/1) and creatinine to 193//mol/l (normal range 70-106 /¿mo 1/1) indicated a moderate renal insufficiency. The protein and ketone body reaction in urine was slightly positive.
Protein in CSF was slightly increased (530 mg/1; normal value for age 150-450 mg/1), as was lactate (1690 /¿mol/1; normal range 1200-1600 /¿mol/1). The concentration of glu cose was normal. There was no clinical or lab oratory evidence for endocrinological immunological3 and chronic infectious dis eases, vitamin deficiency, or disorders caused by toxic agents.
Electroencephalography showed a gener alised slowing background pattern consistent with encephalopathy. During the acute phase cerebral CT showed thin lateral ventricles indicative of cerebral oedema. Electro myography showed normal results. Electro cardiography showed signs of left ventricle hypertrophy and repolarisation disturbances. Two years later the results of EEG, cerebral CT, and E C G were normal.
D iagnostic investigations CLINICAL CHEMICAL ASPECTS
After the patient had made a complete recovery, biochemical studies were performed to determine the aetiology of the rhabdomyolysis. The activity of carnitine palmitoyltrans ferase I and II in leucocytes was normal. Serial measurements of carnitine in serum1 8 showed a concentration of non-esterified car nitine in serum fluctuating between 6 and 38 jiimoVl (table) with a mean level of 21 //mo 1/1 (controls > 20 (mean 38 /tmol/1)), Organic acids were determined in urine by gas chro matography-mass spectrometry. Fast atom bombardment mass spectrometry was used to analyse the excretion profile of acylcarnitines. 19 There was a moderate dicarboxylic aciduria with increased excretion of suberylglycine, with an increase in excretion on pro longed fasting. The acylcarnitine analysis showed increased excretion of almost exclu sively octanoylcarnitine. The identity of these acylcarnitines was confirmed by accurate mass measurements and by linked scanning of the isobutyl esters.
Normal concentrations of amino acids were found in serum and urine. Seram A biopsy from the vastus medialis muscle was taken one month after the rhabdomyolytic period. Only 20% of the fibres were type I (normal 35-50%). In semithin toluidine stained Epon sections there was an increased amount of lipid droplets between the myofib rils, mainly in type I fibres. Electron microscopy showed numerous lipid droplets as well as local glycogen accumulation. Morphometric studies20 showed that the vol ume density of lipid droplets (Vn): volume density of the myofibrils (Vm f) ratio was twice the control mean (Vi/Vm f patient 0-87 (SEM 0-15), controls 0-36 (SEM 0-07)).
BIOCHEMICAL ASPECTS
Concentrations of total and non-esterified carnitine in muscle tissue1 8 were about 25% of control values (table) . The activities of carni tine palmitoyltransferase I and II, citrate syn thase, creatine kinase, cytochrome c oxidase, palmitoyl-CoA synthetase, and succinate dehydrogenase were normal in skeletal mus cle. 2 1 The oxidation rates of radiolabelled palmitate, octanoate, butyrate, and pyruvate by intact cultured fibroblasts were determined according to Veerkamp et ah22 The rate of octanoate was diminished to 5% of the control mean (0*11 v 2-4 (SD 0-9)) nm oLh"1. m g-1 protein. M CAD deficiency was estab lished in fibroblast homogenate (1*6 v 15*6 (6-2) m U.U 1 citrate synthase), using an elec tron transfer fiavoprotein linked assay. 23 The activities of short chain and long chain acyl-CoA dehydrogenases were normal. In a 600 g supernatant of a frozen skeletal muscle speci men, with phenazine methosulphate and dichlorophenolindophenol as electron acceptor,24 M CAD activity was not above the detection limit.
MOLECULAR BIOLOGICAL ASPECTS
Genomic DN A studies were performed on muscle tissue and skin fibroblasts. The D N A was extracted from cultured skin fibroblasts and skeletal muscle homogenate; 2 /¿g was used to amplify an 87 bp region using the polymerase chain reaction (PCR). The oligonucleotide primers used create a restric tion site for Ncol in the mutant fragment. 25 After an initial eight minute denaturation step at 94°C, the PCR reaction was repeated for 30 cycles (one minute denaturation at 94° C; two minutes annealing at 50°C; and three minutes extension at 72°C; the final extension was for eight minutes). The 87 bp PC R prod uct was precipitated and resuspended in 20 ¡A of H 20 . A 10 pi\ aliquot was digested with 5U of Ncol at 37°C for two hours. The original PC R fragment and the products of the restric tion digest were treated by electrophoresis on a 3% agarose gel containing ethidium bromide.
Digestion with Ncol of the amplified D N A from the patient's fibroblasts and muscle showed only 61 and 26 bp fragments and no 87 bp fragment (fig 1, lanes 8 and 10) . Therefore the patient was apparently homozy gous for the 985 point mutation. The synthesis and stability of the M C A D protein was estimated in cultured skin fibroblasts. The normal medium for growing cells was Eagle's minimum essential medium (E-MEM) supplemented with 10% fetal calf serum (FCS) and antibiotics. For [3 5 S] methionine incorporation experiments medium was removed from confluent mono layers. Each dish (area 65 cm2) was washed twice with phosphate buffered saline (PBS) and incubated at 37°C for two hours with 5 ml labelling medium (E-MEM without methionine but with 10% FCS). This medium was replaced by 5 ml of fresh labelling medium containing L-PS]methion ine (100 jx d ). After incubation for one hour at 37°C the medium was removed. In some experiments the degradation of the synthe sised protein was studied by incubating the cells for another six or 17 hours in normal medium with added unlabelled methionine. The cell layers were rinsed twice with PBS containing 2% unlabelled methionine and sol ubilised by the addition of 1 ml NETS medium (150 mM NaCl3 10 m M EDTA3 0*5% Triton X-1005 0*25% sodium dodecylsulphate, and 2% unlabelled methionine, pH 7*4). The cell extract was centrifuged for one hour at 50 000 g. The supernatant was mixed with antiserum raised against pig liver M C A D /6 and incubated overnight at 4°C. The antigen-antibody complex was precipi tated by adding 100 /¿I of Staphylococcus aureus cell suspension^ followed by centrifuga tion (10 minutes at 1700 g). The pellet was washed four times with 2 ml of buffer contain ing 150 ml NaCl, 10 mM Tris-HCl, 1% Triton X-100, 1% deoxycholate, and 0-1% sodium dodecylsulphate, pH 7*2. The washed immunoprecipitate was solubilised by boiling (five minutes) in 50 /d of a denaturating buffer containing 8% mercaptoethanol and 0*003% bromophenol blue. After 10 minutes centrifugation at 6000 g the supernatant was subjected to SDS-PAGE electrophoresis according to Laemmli,2 7 with 12% gels. The gels were treated for fluorography with A u to fluor (Amersham, Buckinghamshire, UK), dried, and fluorographed according to the supplier's instructions. Figure 2 shows the representative M CA D synthesis pattern. The MCAD protein was synthesised by the patient's fibroblasts at a normal rate (lane 1). The rapid disappearance of the protein incorporated radiolabelled methionine suggests a reduced stability of the protein (lanes 2 and 3) . This is likely due to the impaired ability of the mutant 44 kDa monomers to form a stable tetramer.28^0 C a rn itin e treatm ent The patient was treated with 8 g DL-carnitine daily for nine months. During the first month of carnitine supplementation the patient noticed an improvement in his general condi tion. Total carnitine concentrations in serum increased to near normal values and became more constant. The concentration of carnitine in muscle after nine months of carnitine treat ment had not increased (table), and lipid accumulation between the myofibrils had not disappeared. Supplementation was stopped as no objective improvement was seen.
Supplementation of 6 g/day riboflavin (the precursor of the flavin moiety of MCAD) had no beneficial effect.
P hysiological tests
These tests were performed after informed consent of the patient.
FASTING STUDIES
Prolonged fasting studies were performed before the diagnosis of MCAD deficiency was established. The blood concentrations of the most important metabolites were determined before and after the patient had been treated with carnitine for 40 days. Figure 3 shows the results. The concentration of non-esterified fatty acids and ketone bodies increased during fastings whereas the ratio of ketone bodies:non-esterified fatty acids declined to 0*33 at 48 hours without carnitine supple mentation. Glucose concentrations remained above 4*2 mmol/1 for 48 hours, but declined Hours of fasting at 55 hours to 3*0 mmol/1. A more pro nounced ketogenic response to fasting was found during carnitine treatment, whereas the non-esterified fatty acid concentration remained normal. The ketone bo dies: nonesterified fatty acids ratio was 0*68 after a 48 hour fast. Glucose concentrations were maintained at 4-4 mmol/1. Apparently, the low carnitine concentrations had some patho physiological consequences besides the M C A D deficiency.
EXERCISE TESTS
The patient participated in two prolonged exercise tests3 1 (again before the diagnosis was made), one before and one during carnitine treatment. The patient became confused and experienced myalgia and nausea at the end of the exercise test without carnitine. The nor mal glucose concentration could no longer be maintained and lactate and ammonia concen trations showed a pronounced rise. During carnitine treatment he performed the pro longed exercise test with only slight myalgia and felt well after finishing. The glucose, lac tate, and ammonia concentrations did not become abnormal on this occasion.
D iscussion
Since 1982 M C A D deficiency has been recognised in young children with episodic ill ness resembling Reye syndrome, provoked by viral illness, fever, and fasting. 12 32-34 The first episode is often before the age of 2 years.1235
The patients show a broad range of clinical presentation-namely, intolerance to fasting, episodic vomiting, lethargy, altered conscious ness, and even coma. The outcome may be severe and fatal, although complete recovery has also been described. 16 Dependent on the degree of involvement of the liver, heart, and skeletal muscle, the clinical features may range from recurrent episodes of hypogly-caemia to progressive muscle weakness and myalgia. Serum creatine kinase may be mod erately increased. In many patients the mus cular symptoms are not prominent, but some have symptoms of muscle weakness. Techniques such as gas chromatographymass spectrometry and fast atom bombard ment mass spectrometry make it possible to establish this metabolic disorder easily. Recently the value of measuring octanoylcarnitine in plasma from patients suspected to have M CAD deficiency has been stressed. 1 5 Deficiency of M CAD has been associated with a molecular lesion involving an A to G nucleotide replacement at position 985 of the M C A D coding sequence,1 7 resulting in replacement of lysine329 by glutamic acid. 30 Although the prevalence of this mutation is high in patients deficient in M CAD, this approach is not yet appropriate to diagnose all patients with M CAD deficiency. 30 37 Until now only one asymptomatic adult with M CAD deficiency has been described,16 but his genotype was not established. We report the first patient with the M CA D point mutation at nucleotide position 985 whose clinical symptoms appeared at an adult age, whose medical history did not include muscle problems during childhood, and who did not have a positive family history. The clinical presentation of M CAD deficiency in this patient consisted of acute rhabdomyolysis and transient encephalopathy, provoked by pro longed exertion and fasting. Hitherto, rhabdomyolysis has not been associated with M C A D deficiency, although it has recently been described in several other defects of fatty acid oxidation.8-10 Fatty acids are important substrates for skeletal muscle, especially dur ing prolonged exercise and fasting. The decreased oxidative capacity of muscle tissue can result in a moderate accumulation of lipid droplets.
The transient encephalopathy in the pre-sent patient may be considered as a complica tion of rhabdomyolysis or a diminished supply of ketone bodies to the brain. The metabolism of the brain depends on glucose oxidation and, during fasting, on the oxidation of ketone bodies. Fatty acids are hardly metabolised by brain tissue. When the excess of medium chain fatty acids can no longer be metabolised by /^-oxidation, as occurs in M C A D defi ciency, ketogenesis becomes impaired and co oxidation takes place. The impaired oxidation of octanoate may also have contributed to the development of encephalopathic symptoms. Octanoate disturbs the excretion of organic anionic compounds and mitochondrial func tioning, especially in the choroid plexus.38 It also induces epileptic and encephalopathic symptoms. Carnitine supplementation can stimulate detoxification of octanoate by esterification, after which octanoylcarnitine is rapidly excreted. The main dietary advice for patients with disorders of fatty acid oxidation is to have an adequate carbohydrate intake at regular times.1 4 The supplementation of this patient's diet with carnitine may have improved exer cise tolerance and protected against the meta bolic consequences of prolonged fasting.
It is remarkable that in our patient, with the aberrant clinical symptoms, the same point mutation and the same biochemical features have been found as in the far more severe cases of M CAD deficiency. Our patient shows the mutation in both alleles. The question arises as to which factor(s) determine this clinical heterogeneity. It has been shown that the 985 point mutation results in a diminished concentration of M CAD protein as a conse quence of an enhanced degradation rate of the protein.2930 Recently, other point mutations, some of them being localised on exon 11 like the 985 mutation, have been found especially in compound heterozygotes.3037 40"42 Possibly environmental factors or the relative activity of the other enzymes of ^-oxidation play a part in determining the phenotype in patients deficient in M C A D . It is important to realise that in adults with unexplained rhabdomyolysis and acute encephalopathy a diagnosis of M CAD deficiency, or other disturbances in fatty acid oxidation, should be considered. 
